Meanwhile, in the mid-term (2012–2017), “vascular endothelial growth factor-c,” “lymphangiogenesis,” and “vegf-d promotes” emerged, and in the later stage (from 2018 to the present), “tumor microenvironment,” “metastasis,” and “blood vessels” surfaced. The gene discussed is VEGFD; the disease is neoplasm.